FDA Inspection 1192265 — AAP Implantate Ag

AAP Implantate Ag — FEI 3001406084

The FDA completed an inspection of AAP Implantate Ag on Nov 4, 2022 in Berlin. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 4, 2022
Fiscal Year
2023
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Berlin (Germany)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.